Balance Sheet Danone

Equities

BN

FR0000120644

Food Processing

Real-time Euronext Paris Other stock markets 15:14:55 22/04/2026 BST			5-day change	1st Jan Change
68.38 ^EUR	+2.95%		+0.71%	-10.94%

01:55pm	From paint to planes, Iran war lifts costs, darkens outlooks	RE
01:52pm	Risk On, Reality Off

c5080.RCb8uVkbfKhJxqkXhuwnyI-mYPq8oHVqz5WJHccPICE.A1bN9xFVLdE5nMog96ASmOiLC8nFyzQLutuwV4l3bUMCV63KPUk35jyT5A

Published financial data: DANONE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	24.28B	27.66B	27.62B	27.38B	27.28B
Total Revenues	24.28B	27.66B	27.62B	27.38B	27.28B
Cost of Goods Sold, Total	12.76B	14.92B	14.54B	13.77B	13.47B
Gross Profit	11.52B	12.74B	13.08B	13.61B	13.81B
Selling General & Admin Expenses, Total	7.84B	8.93B	9.04B	9.5B	9.56B
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	338M	339M	398M	447M	479M
Other Operating Expenses	5M	86M	159M	150M	99M
Other Operating Expenses, Total	8.19B	9.36B	9.59B	10.1B	10.14B
Operating Income	3.34B	3.38B	3.49B	3.51B	3.67B
Interest Expense, Total	-323M	-308M	-513M	-600M	-498M
Interest And Investment Income	156M	155M	341M	-	301M
Net Interest Expenses	-167M	-153M	-172M	-600M	-197M
Income (Loss) On Equity Invest.	585M	-32M	36M	30M	92M
Other Non Operating Income (Expenses)	-95M	-157M	-185M	220M	-206M
EBT, Excl. Unusual Items	3.66B	3.04B	3.17B	3.16B	3.36B
Restructuring Charges	-1.03B	-419M	-103M	-322M	-365M
Merger & Related Restructuring Charges	-	-	-	-	-66M
Impairment of Goodwill	-7M	-400M	-47M	-	-
Gain (Loss) On Sale Of Assets	8M	2M	-1.13B	310M	-63M
Asset Writedown	-45M	-258M	-48M	-51M	-225M
Other Unusual Items	-4M	-165M	-123M	-68M	-9M
EBT, Incl. Unusual Items	2.58B	1.8B	1.72B	3.03B	2.63B
Income Tax Expense	589M	778M	768M	929M	741M
Earnings From Continuing Operations	1.99B	1.02B	953M	2.1B	1.89B
Net Income to Company	1.99B	1.02B	953M	2.1B	1.89B
Minority Interest	-67M	-64M	-72M	-79M	-63M
Net Income - (IS)	1.92B	959M	881M	2.02B	1.82B
Preferred Dividend and Other Adjustments	26M	13M	8M	4M	8M
Net Income to Common Incl Extra Items	1.9B	946M	873M	2.02B	1.82B
Net Income to Common Excl. Extra Items	1.9B	946M	873M	2.02B	1.82B
Per Share Items
Net EPS - Basic	2.94	1.48	1.36	3.14	2.83
Basic EPS - Continuing Operations	2.94	1.48	1.36	3.14	2.83
Basic Weighted Average Shares Outstanding	646M	639M	641M	643M	643M
Net EPS - Diluted	2.94	1.48	1.36	3.13	2.82
Diluted EPS - Continuing Operations	2.94	1.48	1.36	3.13	2.82
Diluted Weighted Average Shares Outstanding	646M	639M	642M	644M	645M
Normalized Basic EPS	3.43	2.87	2.98	2.95	3.16
Normalized Diluted EPS	3.43	2.87	2.98	2.94	3.15
Dividend Per Share	1.94	2	2.1	2.15	2.25
Payout Ratio	67.67	129.09	145.18	66.7	75.56
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	4.54B	4.25B	4.75B	4.36B	4.47B
EBITA	3.44B	3.49B	3.6B	3.64B	3.8B
EBIT	3.34B	3.38B	3.49B	3.51B	3.67B
Effective Tax Rate - (Ratio)	22.83	43.2	44.63	30.67	28.19
Total Current Taxes	663M	738M	814M	868M	800M
Total Deferred Taxes	-73M	40M	-46M	61M	-59M
Normalized Net Income	2.22B	1.84B	1.91B	1.9B	2.04B
Interest on Long-Term Debt	1M	2M	-	-	-
Non-Cash Pension Expense	-21M	26M	32M	41M	39M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.52B	6.29B	6.29B	6.57B	6.57B
General and Administrative Expenses	2.33B	2.64B	2.75B	2.93B	3B
Research And Development Expense From Footnotes	338M	339M	398M	447M	479M
Stock-Based Comp., Other (Total)	13M	25M	61M	71M	109M
Total Stock-Based Compensation	13M	25M	61M	71M	109M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	659M	1.05B	2.36B	1.48B	1.98B
Short Term Investments	5.2B	3.63B	3.64B	4.68B	4.59B
Total Cash And Short Term Investments	5.86B	4.68B	6B	6.16B	6.57B
Accounts Receivable, Total	2.86B	3.27B	2.92B	2.92B	3.04B
Other Receivables	746M	867M	887M	976M	802M
Notes Receivable	8M	3M	3M	2M	2M
Total Receivables	3.62B	4.14B	3.81B	3.9B	3.85B
Inventory	1.98B	2.62B	2.34B	2.28B	2.32B
Other Current Assets, Total	602M	710M	765M	449M	488M
Total Current Assets	12.06B	12.15B	12.92B	12.79B	13.23B
Gross Property Plant And Equipment	16.02B	16.64B	16.06B	16.94B	16.79B
Accumulated Depreciation	-9.18B	-9.89B	-9.62B	-10.42B	-10.34B
Net Property Plant And Equipment	6.84B	6.75B	6.44B	6.52B	6.44B
Long-term Investments	1.33B	1.37B	1.13B	1.32B	1.51B
Goodwill	17.87B	17.94B	17.34B	18.06B	17.28B
Other Intangibles, Total	6.18B	6.3B	5.75B	5.95B	5.86B
Loans Receivable Long-Term	16M	11M	10M	6M	8M
Deferred Tax Assets Long-Term	890M	735M	746M	528M	534M
Other Long-Term Assets, Total	233M	21M	148M	123M	205M
Total Assets	45.42B	45.28B	44.49B	45.29B	45.07B
Liabilities
Accounts Payable, Total	4B	4.9B	4.78B	5.15B	5.42B
Accrued Expenses, Total	2.62B	3.04B	2.96B	3.2B	3.38B
Short-term Borrowings	757M	786M	1.62B	1.01B	1.36B
Current Portion of Long-Term Debt	3.08B	2.64B	3.72B	3.4B	3.48B
Current Portion of Leases	215M	203M	192M	213M	207M
Other Current Liabilities	413M	567M	561M	755M	783M
Total Current Liabilities	11.08B	12.13B	13.83B	13.73B	14.62B
Long-Term Debt	11.77B	10.51B	10.05B	9.52B	9.34B
Long-Term Leases	767M	730M	687M	655M	730M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	1.07B	745M	873M	870M	739M
Deferred Tax Liability Non Current	1.5B	1.58B	1.49B	1.48B	1.46B
Other Non Current Liabilities	1.85B	1.59B	1.33B	1.18B	1.2B
Total Liabilities	28.04B	27.29B	28.26B	27.44B	28.1B
Common Stock, Total	172M	169M	169M	170M	170M
Additional Paid In Capital	5.93B	5.19B	5.26B	5.33B	5.42B
Retained Earnings	18.04B	16.67B	16.34B	17.05B	17.58B
Treasury Stock	-2.38B	-1.57B	-1.55B	-1.53B	-1.98B
Comprehensive Income and Other	-4.49B	-2.53B	-4.04B	-3.22B	-4.28B
Total Common Equity	17.27B	17.92B	16.18B	17.8B	16.92B
Minority Interest	102M	69M	46M	59M	52M
Total Equity	17.38B	17.99B	16.22B	17.85B	16.97B
Total Liabilities And Equity	45.42B	45.28B	44.49B	45.29B	45.07B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	638M	640M	642M	644M	640M
ECS Total Common Shares Outstanding	638M	640M	642M	644M	640M
Book Value / Share	27.07	28.02	25.2	27.63	26.43
Tangible Book Value	-6.78B	-6.32B	-6.92B	-6.21B	-6.22B
Tangible Book Value Per Share	-10.63	-9.87	-10.78	-9.65	-9.71
Total Debt	16.59B	14.87B	16.27B	14.8B	15.12B
Net Debt	10.73B	10.18B	10.27B	8.64B	8.55B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.07B	745M	873M	871M	739M
Minority Interest, Total (Incl. Fin. Div)	102M	69M	46M	59M	52M
Equity Method Investments, Total	771M	576M	416M	583M	730M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	944M	1.04B	849M	1.29B	1.2B
Inventories - Work In Process, Total	209M	244M	287M	-	-
Inventories - Finished Goods, Total	1.01B	1.37B	1.31B	1.22B	1.33B
Inventories - Others	-	197M	181M	-	-
Land - (BS)	4.81B	5.24B	5.16B	5.23B	5.13B
Machinery, Total	8.76B	8.96B	8.47B	9.26B	9.12B
Full Time Employees	98.1K	96.17K	88.84K	89.53K	88.67K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	94M	98M	123M	113M	109M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.92B	959M	881M	2.02B	1.82B
Depreciation & Amortization - CF	1.1B	981M	1.35B	921M	883M
Amortization of Goodwill and Intangible Assets - (CF)	103M	106M	107M	125M	131M
Depreciation & Amortization, Total	1.21B	1.09B	1.45B	1.05B	1.01B
(Gain) Loss From Sale Of Asset	-31M	78M	-7M	-225M	-1M
Asset Writedown & Restructuring Costs	57M	776M	158M	122M	341M
(Income) Loss On Equity Investments - (CF)	-564M	53M	-13M	-7M	-68M
Stock-Based Compensation (CF)	12M	25M	61M	71M	109M
Other Operating Activities, Total	516M	-91M	632M	270M	284M
Change In Accounts Receivable	-231M	-424M	74M	-7M	-328M
Change In Inventories	-81M	-667M	41M	50M	-192M
Change In Accounts Payable	425M	879M	324M	353M	527M
Change in Other Net Operating Assets	239M	289M	-162M	137M	268M
Cash from Operations	3.47B	2.96B	3.44B	3.83B	3.78B
Capital Expenditure	-1.04B	-873M	-847M	-923M	-1.06B
Sale of Property, Plant, and Equipment	46M	30M	15M	18M	44M
Cash Acquisitions	-	-100M	-162M	-153M	-858M
Divestitures	-	206M	177M	507M	106M
Investment in Marketable and Equity Securities, Total	1.53B	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	24M	-12M	-17M	87M	-9M
Other Investing Activities, Total	-	-	-	1M	-1M
Cash from Investing	561M	-749M	-834M	-463M	-1.77B
Long-Term Debt Issued, Total	2.2B	600M	2.17B	1.4B	2.25B
Total Debt Issued	2.2B	600M	2.17B	1.4B	2.25B
Long-Term Debt Repaid, Total	-2.54B	-2.71B	-2.6B	-2.81B	-2.05B
Total Debt Repaid	-2.54B	-2.71B	-2.6B	-2.81B	-2.05B
Issuance of Common Stock	46M	51M	69M	76M	89M
Repurchase of Common Stock	-801M	-	-	-	-486M
Common Dividends Paid	-1.3B	-1.24B	-1.28B	-1.35B	-1.38B
Common & Preferred Stock Dividends Paid	-1.3B	-1.24B	-1.28B	-1.35B	-1.38B
Other Financing Activities, Total	-1.62B	1.37B	-419M	-1.13B	-30M
Cash from Financing	-4.03B	-1.93B	-2.06B	-3.82B	-1.61B
Foreign Exchange Rate Adjustments	58M	112M	-503M	-2M	-307M
Miscellaneous Cash Flow Adjustments	-	-1M	1M	-1M	1M
Net Change in Cash	66M	392M	49M	-452M	90M
Supplemental Items
Cash Interest Paid	-	18M	18M	5M	5M
Cash Income Tax Paid (Refund)	569M	716M	730M	766M	697M
Levered Free Cash Flow	3.07B	2.36B	2.88B	2.96B	2.49B
Unlevered Free Cash Flow	3.28B	2.56B	3.2B	3.33B	2.8B
Change In Net Working Capital	-1.01B	-202M	-349M	-945M	-442M
Net Debt Issued / Repaid	-345M	-2.11B	-428M	-1.42B	196M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.73	4.66	4.86	4.89	5.07
Return on Total Capital	6.24	6.33	6.68	6.73	7.08
Return On Equity %	11.83	5.78	5.57	12.33	10.84
Return on Common Equity	11.34	5.38	5.12	11.87	10.47
Margin Analysis
Gross Profit Margin %	47.45	46.05	47.37	49.7	50.62
SG&A Margin	32.3	32.29	32.72	34.7	35.05
EBITDA Margin %	18.71	15.38	17.2	15.94	16.38
EBITA Margin %	14.16	12.61	13.03	13.28	13.92
EBIT Margin %	13.74	12.23	12.64	12.82	13.44
Income From Continuing Operations Margin %	8.2	3.7	3.45	7.67	6.92
Net Income Margin %	7.92	3.47	3.19	7.38	6.69
Net Avail. For Common Margin %	7.82	3.42	3.16	7.37	6.66
Normalized Net Income Margin	9.14	6.64	6.91	6.93	7.46
Levered Free Cash Flow Margin	12.66	8.54	10.42	10.8	9.13
Unlevered Free Cash Flow Margin	13.49	9.24	11.58	12.17	10.27
Asset Turnover
Asset Turnover	0.55	0.61	0.62	0.61	0.6
Fixed Assets Turnover	3.62	4.07	4.19	4.22	4.21
Receivables Turnover (Average Receivables)	8.88	9.02	8.92	9.37	9.15
Inventory Turnover (Average Inventory)	6.68	6.49	5.86	5.96	5.86
Short Term Liquidity
Current Ratio	1.09	1	0.93	0.93	0.9
Quick Ratio	0.85	0.73	0.71	0.73	0.71
Operating Cash Flow to Current Liabilities	0.31	0.24	0.25	0.28	0.26
Days Sales Outstanding (Average Receivables)	41.11	40.47	40.91	39.05	39.89
Days Outstanding Inventory (Average Inventory)	54.66	56.27	62.28	61.38	62.34
Average Days Payable Outstanding	105.59	104.36	123.89	132.54	142.64
Cash Conversion Cycle (Average Days)	-9.82	-7.62	-20.7	-32.12	-40.41
Long Term Solvency
Total Debt/Equity	95.46	82.63	100.31	82.91	89.09
Total Debt / Total Capital	48.84	45.24	50.08	45.33	47.12
LT Debt/Equity	72.16	62.46	66.21	56.99	59.36
Long-Term Debt / Total Capital	36.92	34.2	33.05	31.16	31.39
Total Liabilities / Total Assets	61.75	60.27	63.53	60.58	62.35
EBIT / Interest Expense	10.33	10.98	6.81	5.85	7.37
EBITDA / Interest Expense	14.07	14.51	9.64	7.59	9.4
(EBITDA - Capex) / Interest Expense	10.84	11.68	7.99	6.06	7.28
Total Debt / EBITDA	3.65	3.33	3.29	3.25	3.23
Net Debt / EBITDA	2.36	2.28	2.08	1.9	1.83
Total Debt / (EBITDA - Capex)	4.74	4.13	3.97	4.07	4.17
Net Debt / (EBITDA - Capex)	3.07	2.83	2.51	2.38	2.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.8	13.92	-0.15	-0.88	-0.34
Gross Profit, 1 Yr. Growth %	1.48	10.57	2.71	4	1.49
EBITDA, 1 Yr. Growth %	2.83	2.6	11.66	-8.15	1.29
EBITA, 1 Yr. Growth %	0.35	1.48	3.12	1.03	3.09
EBIT, 1 Yr. Growth %	0.18	1.44	3.19	0.54	3.03
Earnings From Cont. Operations, 1 Yr. Growth %	-1.92	-48.62	-6.84	120.36	-10.1
Net Income, 1 Yr. Growth %	-1.64	-50.16	-8.13	129.4	-9.7
Normalized Net Income, 1 Yr. Growth %	10.84	-17.24	3.95	-0.69	5.6
Diluted EPS Before Extra, 1 Yr. Growth %	-1.73	-49.61	-8.11	130.15	-9.9
Accounts Receivable, 1 Yr. Growth %	9.74	14.33	-10.79	0.1	4.11
Inventory, 1 Yr. Growth %	7.72	32.14	-10.61	-2.73	2.11
Net Property, Plant and Equip., 1 Yr. Growth %	4.12	-1.33	-4.61	1.21	-1.14
Total Assets, 1 Yr. Growth %	6.18	-0.31	-1.76	1.81	-0.49
Tangible Book Value, 1 Yr. Growth %	-0.75	-6.84	9.53	-10.19	0.1
Common Equity, 1 Yr. Growth %	6.59	3.76	-9.75	10.01	-4.93
Cash From Operations, 1 Yr. Growth %	17.09	-14.68	16.13	11.3	-1.36
Capital Expenditures, 1 Yr. Growth %	8.42	-16.3	-2.98	8.97	14.3
Levered Free Cash Flow, 1 Yr. Growth %	249.31	-18.68	21.77	-2.42	-16.65
Unlevered Free Cash Flow, 1 Yr. Growth %	196.78	-17.76	25.14	-0.57	-16.69
Dividend Per Share, 1 Yr. Growth %	0	3.09	5	2.38	4.65
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.01	8.22	6.65	-0.52	-0.61
Gross Profit, 2 Yr. CAGR %	-3.64	5.93	6.57	3.35	2.74
EBITDA, 2 Yr. CAGR %	-5.55	-1.87	7.04	1.27	-2.99
EBITA, 2 Yr. CAGR %	-6.93	0.92	2.3	2.07	2.76
EBIT, 2 Yr. CAGR %	-7.15	0.81	2.31	1.86	2.5
Earnings From Cont. Operations, 2 Yr. CAGR %	-0.92	-29.01	-30.82	43.28	40.75
Net Income, 2 Yr. CAGR %	-0.13	-29.98	-32.33	45.17	43.93
Normalized Net Income, 2 Yr. CAGR %	3.85	-4.23	-7.25	1.6	3.24
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.21	-29.64	-31.96	45.43	44
Accounts Receivable, 2 Yr. CAGR %	-0.76	12.01	0.99	-5.5	2.09
Inventory, 2 Yr. CAGR %	1.26	19.3	8.68	-6.76	-0.34
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.01	1.36	-2.98	-1.74	0.03
Total Assets, 2 Yr. CAGR %	0.06	2.89	-1.03	0.01	0.66
Tangible Book Value, 2 Yr. CAGR %	-5.31	-3.84	1.01	-0.82	-5.19
Common Equity, 2 Yr. CAGR %	0.09	5.17	-3.23	-0.36	2.26
Cash From Operations, 2 Yr. CAGR %	0.43	-0.05	-0.46	13.69	4.78
Capital Expenditures, 2 Yr. CAGR %	4.73	-4.74	-9.88	2.82	11.61
Levered Free Cash Flow, 2 Yr. CAGR %	15.96	63.87	-0.49	11.88	-9.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.66	52.17	1.45	14.2	-8.56
Dividend Per Share, 2 Yr. CAGR %	-3.88	1.53	4.04	3.68	3.51
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.5	3.04	5.35	4.08	-0.46
Gross Profit, 3 Yr. CAGR %	-1.13	0.88	4.84	5.7	2.73
EBITDA, 3 Yr. CAGR %	0.17	-5.82	2.44	1.72	1.66
EBITA, 3 Yr. CAGR %	-2.6	-4.21	1.65	1.87	2.88
EBIT, 3 Yr. CAGR %	-2.72	-4.37	1.6	1.72	2.73
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.54	-20.4	-22.28	1.79	22.66
Net Income, 3 Yr. CAGR %	-6.44	-20.78	-23.35	1.65	23.92
Normalized Net Income, 3 Yr. CAGR %	-3.27	-3.72	-1.57	-5.11	3.48
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.81	-20.54	-23.09	2.14	23.97
Accounts Receivable, 3 Yr. CAGR %	2.1	4.03	3.83	0.69	-2.4
Inventory, 3 Yr. CAGR %	3.47	10.65	8.36	4.73	-3.89
Net Property, Plant and Equip., 3 Yr. CAGR %	3.48	-0.45	-0.67	-1.6	-1.54
Total Assets, 3 Yr. CAGR %	0.93	-0.06	1.32	-0.09	-0.15
Tangible Book Value, 3 Yr. CAGR %	-5.76	-5.82	0.42	-2.87	-0.51
Common Equity, 3 Yr. CAGR %	1.86	1.3	-0.06	1	-1.91
Cash From Operations, 3 Yr. CAGR %	3.75	-4.88	5.07	3.31	8.43
Capital Expenditures, 3 Yr. CAGR %	3.49	-2.81	-4.16	-3.99	6.52
Levered Free Cash Flow, 3 Yr. CAGR %	15.69	1.12	48.43	0.6	1.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.67	0.26	42.57	2.36	3.12
Dividend Per Share, 3 Yr. CAGR %	0	-1.61	2.68	3.49	4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.04	2.2	2.3	1.6	2.93
Gross Profit, 5 Yr. CAGR %	0.57	0.9	1.88	1.86	4
EBITDA, 5 Yr. CAGR %	3.57	-0.84	1	-3.05	0.23
EBITA, 5 Yr. CAGR %	1.91	-1.09	-0.67	-1.74	2.09
EBIT, 5 Yr. CAGR %	1.75	-1.2	-0.74	-1.92	1.96
Earnings From Cont. Operations, 5 Yr. CAGR %	1.73	-16.75	-17.13	0.7	-1.44
Net Income, 5 Yr. CAGR %	2.27	-17.1	-17.81	0.94	-1.38
Normalized Net Income, 5 Yr. CAGR %	6.38	-1.24	-4.88	-1.63	0.33
Diluted EPS Before Extra, 5 Yr. CAGR %	1.03	-17.62	-17.83	1.19	-1.16
Accounts Receivable, 5 Yr. CAGR %	2.55	3.21	1.66	0.11	3.13
Inventory, 5 Yr. CAGR %	7.51	9.44	5.53	3.33	4.79
Net Property, Plant and Equip., 5 Yr. CAGR %	6.32	2.37	0.85	-0.97	-0.39
Total Assets, 5 Yr. CAGR %	0.66	0.46	0.14	-0.03	1.05
Tangible Book Value, 5 Yr. CAGR %	20.27	-9.65	-3.11	-3.85	-1.86
Common Equity, 5 Yr. CAGR %	5.67	4.39	-0.21	0.63	0.86
Cash From Operations, 5 Yr. CAGR %	5.55	0.04	2.04	2.15	4.96
Capital Expenditures, 5 Yr. CAGR %	2.43	-2.06	-2.08	-0.6	1.86
Levered Free Cash Flow, 5 Yr. CAGR %	17.14	3.64	7.71	5.29	23.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.9	2.72	7.47	5.62	20.49
Dividend Per Share, 5 Yr. CAGR %	2.68	1.03	1.6	0.47	3.01